CytoMed Therapeutics Ltd
GDTC Nasdaq
SEC CIK 1873093
Follow CytoMed Therapeutics
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −SGD 4M |
| FY24 | −SGD 2.5M |
| FY23 | −SGD 4.1M |
| FY22 | −SGD 3.1M |
| FY21 | −SGD 2.1M |
| FY20 | −SGD 1.9M |
| FY19 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −SGD 4.3M |
| FY24 | −SGD 4.1M |
| FY23 | −SGD 3.6M |
| FY22 | −SGD 1.9M |
| FY21 | −SGD 2.3M |
| FY20 | −SGD 1.1M |
| FY19 | - |